Evaluation of Neuroprotective Effects of Dehydrozingerone in Experimental Models of Alzheimer’s Disease

Created using ChatSlide

This project provides a comprehensive exploration of Dehydrozingerone (DHZ) as a potential therapeutic agent for Alzheimer's Disease (AD), addressing current challenges and knowledge gaps. With Alzheimer’s incidence projected to rise, this study aims to assess the neuroprotective effects of DHZ, focusing on improving cognitive function and reducing oxidative stress by modulating AD pathways. Methodologies include DHZ synthesis, cell viability studies, and animal research, followed by rigorous...